Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 285-480-1 | CAS number: 85099-25-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 8th January 1986 to 30th January 1986.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study, not GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- Not relevant
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Details on test material:
- Polycat 8CAS 98-94-2 (cyclohexyldimethylamine), N,N-dimethylcyclohexylamine (DMCHA)purity not indicated Lot # 79-507-CJLiquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: Interfauna U.K. Limited, Wyton, Huntingdon.- Age at study initiation: ten to fourteen weeks old. - Weight at study initiation: Males: 200 - 254g Females: 200 - 245g- Fasting period before study: Not documented- Housing: Housed in polypropylene cages with sawdust bedding.- Diet (e.g. ad libitum): Rat and Mouse Expanded Diet No. 1 ad libitum- Water (e.g. ad libitum): Mains drinking water ad libitum- Acclimation period: Not documentedENVIRONMENTAL CONDITIONS- Temperature (°C): 19 - 22°C- Humidity (%): 45 - 60%- Air changes (per hr): Approximately 15 changes per hour- Photoperiod (hrs dark / hrs light): 12 hours light / 12 hours darkIN-LIFE DATES: From: 8 January 1986 To: 30 January 1986
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE- Area of exposure: Back and flanks of each animal, approximately 6 x 12 cm.- % coverage: Approximately 10%- Type of wrap if used: A sheet of aluminium foil (7 x 4cm) was placed over the treatment area and occluded with a double layer of adhesive strapping (SLEEK) wrapped around the trunk of the rat.REMOVAL OF TEST SUBSTANCE- Washing (if done): Yes - the test area and surrounding hair were wiped with moist absorbant paper to remove any residual test sample. - Time after start of exposure: After the 24 hour contact periodTEST MATERIAL- Amount(s) applied (volume or weight with unit): 0.36, 0.43, 0.50 and 0.59 ml/kg.
- Duration of exposure:
- 24 hours
- Doses:
- 300, 360, 420, 500 mg/kg bw
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- no
- Details on study design:
- EXAMINATIONS: 14 days observation period mortality/clinical signs 1 and 4 hours after dosing and once daily thereafter body weights prior to dosing and on day 7 and 14 macroscopy on all animals.
- Statistics:
- Weil C.S. (1952), Biometrics 8, 249
Results and discussion
- Preliminary study:
- Not relevant
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 380 mg/kg bw
- Based on:
- not specified
- 95% CL:
- 330 - 440
- Remarks on result:
- other: Three animals (1 male and 2 females) were found dead at the 4 hour observation and one male and female were found dead on day 1.
- Mortality:
- - Time of death: all within 1 day post-dose dose male female all 300 2/5 0/5 2/10 360 2/5 3/5 5/10 420 2/5 4/5 6/10 500 3/5 5/5 8/10
- Clinical signs:
- (a) during exposure: in majority hunched posture, pilo-erection, lethargy, ataxia, decreased respiratory rate or gasping respiration, ptosis, tail arching, (occasional) body tremors. In minority red/brown staining around the eyes and/or nose, tail lashing, increased salivation and/or lacrimation. Incidental tiptoe gait (420 and 360 mg/kg), tonic or clonic convulsions, loss of righting reflex (420 mg/kg) and exophthalmos (300 mg/kg). (b) post-exposure: hunched posture, pilo-erection, lethargy, decreased respiratory rate, ataxia. Symptoms disappeared 2-3 days after treatment.
- Body weight:
- No treatment-related effect
- Gross pathology:
- (a)in animals that died: congested lungs at 360 and 420 mg/kg. Haemorrhage of the subcutis, dark staining or reddening of the treatment site at all doses in all animals dying during the study. In some of these animals the upper layer of skin was peeling away from the underneath skin.(b) in survivors: eschar on the application site with dark areas below eschar formation
- Other findings:
- No additional results
Any other information on results incl. tables
In the preliminary range finding study, the mortalities recorded indicated a dermal LD50 in the range of 500 - 1000 mg/kg. However, mortalities were apparent soon after dosing the initially selected low dose group (500 mg/kg) and the selected dose levels were revised, making the 500 mg/kg the high dose group.
No additional findings were noted in the main test group.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- Under the conditions of the study, the dermal LD50 of DMCHA was determined to be 380 mg/kg (330 - 440 mg/kg 95% confidence limits). Based on these results, the test substance should be classified as a Category 3 acute dermal toxicant according to Regulation EC No. 1272/2008 and should have the signal word Danger and the hazard statement H301: Toxic if swallowed associated with it. In accordance with Directive 67/548/EEC, the test substance should be classified as Toxic (T) and have the risk phrase R24 Toxic in contact with skin associated with it.
- Executive summary:
In a study conducted by Jones and Collier (1986), the test substance, cyclohexyldimethylamine (DMCHA), was examined for its ability to cause acute dermal toxicity when applied to the backs and flanks of male and female Sprague-Dawley rats. A preliminary study was performed to determine the appropriate dose level to use, with 300, 360, 420 and 500 mg/kg being selected as the dose concentrations to use in the main study. The test substance was applied under an occlusive dressing and left in place for 24 hours. Following the 24 hour contact period, the dressing was removed and the test site and surrounding hair was washed with moist absorbent paper to remove any remaining test substance. Deaths were dose related with 2 deaths at 300 mg/kg, 5 deaths at 360 mg/kg, 6 deaths at 420 mg/kg and 8 deaths at 500 mg/kg. All deaths occurred within the first 24 hours and survivors all appeared normal after 3 days, with the exception of skin damage at the treatment site. Signs of toxicity included ataxia, tremors, tail arching and convulsions. At necropsy after 14 days, survivors showed no abnormalities of internal organs but all showed extensive skin damage. Under the conditions of the study, the dermal LD50 of DMCHA was determined to be 380 mg/kg (330 - 440 mg/kg 95% confidence limits). Based on these results, the test substance should be classified as a Category 3 acute dermal toxicant according to Regulation EC No. 1272/2008 and should have the signal word Danger and the hazard statement H311: Toxic in contact with skin
associated with it. In accordance with Directive 67/548/EEC, the test substance should be classified as Toxic (T) and have the risk phrase R24 Toxic in contact with skin associated with it.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.